Key result
Elderly patients (≥75 years) undergoing PCI for chronic total occlusion had similar procedural success to younger patients (78.1% vs 82.8%) but higher long-term all-cause mortality (29.5% vs 8.89%).
Why the study?
To examine the effect of age on procedural and clinical outcomes in patients undergoing PCI of CTO lesions.
Does age ≥75 years worsen procedural and clinical outcomes in patients undergoing percutaneous coronary intervention for chronic total occlusion compared to younger patients?
Systematic Review (n=7,671)
Does age ≥75 years worsen procedural and clinical outcomes in patients undergoing percutaneous coronary intervention for chronic total occlusion compared to younger patients?
Absolute Event Rate: 78.1% vs 82.8%
CTO-PCI is safe and feasible in elderly patients (≥75 years) with short-term outcomes comparable to younger patients, and successful revascularization improves clinical endpoints in both age groups.
Objective To examine the effect of age on procedural and clinical outcomes in patients undergoing percutaneous coronary intervention (PCI) of chronic total occlusion (CTO) lesions.Methods Literature search was conducted across PubMed, Google Scholar and Web of science, databases till March 2019.Results Seven studies including 7671 patients with an overall follow-up period of 1.5 to 5 years were included in our review. A total of 6299/1372 patients were included in non-elderly and elderly groups, respectively, with mean age and 67%/61% male patients. CTO-PCI was similarly successful in younger and older patients (82.8%, n = 5070 vs. 78.1%, n = 1010). The incidence of short-term outcomes was low across the studies and comparable between the two groups (all-cause mortality: 0.4% younger vs. 0.85% elderly, cerebrovascular accidents: 0.3% vs. 0.4%, major adverse cardiovascular events (MACE): 1.53% vs. 3.72% and major bleeding: 0.57% vs. 2.18%). Long-term outcomes including all-cause mortality (8.89% vs. 29.5%), cardiac mortality (3.72% vs. 15%) and MACE (24.9% vs. 40%) occurred with a higher incidence in elderly patients. When results were segregated according to the success of CTO-PCI, reduced clinical events were noted with successful revascularization in either age group.Conclusion Compared with the younger age group, CTO-PCI in elderly patients is safe and feasible with a comparable incidence of short-term outcomes. In either population, the incidence of long-term outcomes including survival remains a concern but when successful, CTO-PCI may be associated with improvement in terms of multiple patient-important clinical end-points.
No takes yet. Share an insight, caveat, or question.
Lateef et al. (2020) conducted a systematic review in Chronic total occlusion (CTO) (n=7,671). Age ≥75 years vs. Age <75 years was evaluated on Procedural success. Elderly patients (≥75 years) undergoing PCI for chronic total occlusion had similar procedural success to younger patients (78.1% vs 82.8%) but higher long-term all-cause mortality (29.5% vs 8.89%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: